SBIR/STTR Research Award

PURIFICATION OF AN AUTOCRINE ANGIOGENESIS INHIBITOR

Award identifier eba958a11b2191a14b492909919b52d717e9c7ae4a0bc5d5c435c88ce6cb401bAwarding agency Department of Health and Human Services

Award amount

$50,000

Program and phase

SBIR · Phase I

Award year

1987

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
California Biotechnology, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

A PROTEIN HAS BEEN IDENTIFIED FROM A CULTURED CELL LINE WHICH INHIBITS THE GROWTH OF CAPILLARY ENDOTHELIAL CELLS IN VITRO. THIS PROTEIN WILL BE PURIFIED FROM CONDITIONED GROWTH MEDIUM AND USED IN IN VITRO AND IN VIVO MODEL SYSTEMSTO TEST ITS ABILITY TO INHIBIT THE FORMATION OF NEW CAPILLARIES. THIS IS THE FIRST STEP TOWARD DEVELOPING A THERAPY THAT WILL BE USED IN THE TREATMENT OF SOLID TUMORS, VARIOUS RETINOPATHIES, PSORIASIS, ARTERIAL OCCLUSIVE DISEASE, AND IN BIRTH CONTROL, ALL OF WHICH INVOLVE EITHER NEOVASCULARIZATION OR GROWTH OF ENDOTHELIAL CELLS THEMSELVES.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.